Bank of Montreal’s Briacell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-234
| Closed | -$19.7K | – | 3159 |
|
|
2024
Q4 | $19.7K | Sell |
234
-2
| -0.8% | -$169 | ﹤0.01% | 2936 |
|
|
2024
Q3 | $27.4K | Sell |
236
-140
| -37% | -$16.3K | ﹤0.01% | 3182 |
|
|
2024
Q2 | $72.1K | Sell |
376
-519
| -58% | -$99.5K | ﹤0.01% | 3051 |
|
|
2024
Q1 | $521K | Buy |
895
+534
| +148% | +$311K | ﹤0.01% | 2136 |
|
|
2023
Q4 | $319K | Buy |
361
+110
| +44% | +$97.1K | ﹤0.01% | 2430 |
|
|
2023
Q3 | $265K | Buy |
251
+20
| +9% | +$21.1K | ﹤0.01% | 2503 |
|
|
2023
Q2 | $217K | Buy |
231
+63
| +38% | +$59.3K | ﹤0.01% | 2798 |
|
|
2023
Q1 | $187K | Buy |
168
+98
| +140% | +$109K | ﹤0.01% | 2787 |
|
|
2022
Q4 | $49.1K | Hold |
70
| – | – | ﹤0.01% | 3105 |
|
|
2022
Q3 | $61 | Buy |
+70
| New | +$61 | ﹤0.01% | 3102 |
|